This public procurement record has 4 releases in its history.

Award

10 May 2018 at 13:52

Award

19 Apr 2018 at 13:34

TenderAmendment

06 Oct 2017 at 09:55

Tender

06 Oct 2017 at 09:52

Summary of the contracting process

The NHS Framework Agreement for the supply of proprietary pharmaceuticals in the North of England is conducted by NHS England, with an advertised value of £521.1 million over a period starting 1 March 2018 and running until 29 February 2020, with an option to extend for up to 24 months. The procurement is at the award stage, with the initial tender period having ended on 7 November 2017, and the framework intended for various NHS entities and potentially private sector contractors. The framework is classified under the CPV code for pharmaceutical products.

This procurement provides significant opportunities for businesses in the pharmaceutical sector, particularly those capable of supplying proprietary medications. Companies that are well-suited for participation include large-scale pharmaceutical manufacturers and SMEs with the capacity to meet the framework's requirements. Engaging with this framework can help businesses expand their market presence, foster relationships within the NHS, and secure long-term contracts that may benefit their growth and sustainability.

How relevant is this notice?

Notice Title

NHS Framework Agreement - North of England - Tranche B

Notice Description

A framework is awarded for the supply of proprietary pharmaceuticals to participating Authorities in the NHS Region: North of England. The period of the resulting framework is 01 March 2018 - 29 February 2020, with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Attached is the model form framework agreement. All of the awarded frameworks were made on the basis of the model form framework agreement. Redacted award schedules have been attached for each of the awarded suppliers.

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-cbf2fcb1-162c-40a1-a1a8-b258187390fb
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/d5f7ca8a-6013-46c6-94ea-631f64bd61b5
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£521,100,000 £100M-£1B
Lots Value
Not specified
Awards Value
£521,100,000 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
10 May 20188 years ago
Submission Deadline
7 Nov 2017Expired
Future Notice Date
Not specified
Award Date
8 Jan 20188 years ago
Contract Period
1 Mar 2018 - 29 Feb 2020 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CHESHIRE
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
32
Supplier Names

Astellas Pharma Ltd

AVENTIS PHARMA LIMITED t-a Sanofi

Bayer Plc

Biogen Idec Limited

OEHRINGER INGELHEIM LIMITED

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED

Daiichi Sankyo UK Ltd

Eli Lilly & Company Ltd

Ferring Pharmaceuticals Ltd

Gedeon Richter UK Ltd

Genzyme Therapeutics Limited

Gilead Sciences Ltd

Intrapharm Laboratories Ltd

Ipsen

Janssen-Cilag Ltd

LEO Pharma

Merck Serono Limited

Mercury Pharmaceuticals Ltd

MSD

Napp Pharmaceuticals Ltd

Novartis Pharmaceuticals UK Limited

Novo Nordisk

Pfizer Ltd

Pharmasure Ltd

Roche Products Ltd

ROVI Biotech Ltd

Sandoz Ltd

Takeda UK Limited

Teva UK Limited

UCB Pharma Ltd

Boehringer Ingelheim

AVENTIS PHARMA LIMITED

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...